Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years

Ariane Baudu; Jean-Luc Prétet; Didier Riethmuller; Morgane Chotard; Christiane Mougin; Mariette Mercier

doi:10.1016/j.jegh.2013.11.003

<Previous Article In Issue

Next Article In Issue>

Volume 4, Issue 1, March 2014, Pages 35 - 43

Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years

Authors

Ariane Baudu^a^{, b}, Jean-Luc Prétet^a^{, b}^{, c}, Didier Riethmuller^a^{, b}^{, c}, Morgane Chotard^b^{, c}, Christiane Mougin^a^{, b}^{, c}^{, *}^,christiane.mougin@univ-fcomte.fr, Mariette Mercier^a^{, b}^{, c}

^aUniv Franche-Comte, F-25000 Besancon, France

^bEA 3181, FED4234, F-25000 Besancon, France

^cCHU Besancon, F-25000, France

^*Corresponding author at: Laboratoire de Biologie Cellulaire et Moléculaire, FED4234, Université de Franche-Comté, Centre Hospitalier Universitaire, Boulevard A Fleming, 25030 Besançon cedex, France. Tel.: +33 3 81 66 91 11; fax: +33 3 81 66 93 70.

Corresponding Author

Christiane Mouginchristiane.mougin@univ-fcomte.fr

Received 15 March 2013, Revised 19 October 2013, Accepted 29 November 2013, Available Online 23 January 2014.

DOI: 10.1016/j.jegh.2013.11.003 How to use a DOI?
Keywords: HPV infection; Genotyping; Young females; Screening; Epidemiology
Abstract: Investigation of the prevalence and risk factors of human papillomavirus (HPV) infection is the basis for developing prophylactic strategies against cervical cancer, especially for young women. This study aimed to assess the prevalence and risk factors of HPV infection among a cohort of sexually active young French women eligible for catch-up vaccination. Between 1997 and 2007, 2163 women aged 15–23 years attending consultations at the department of gynecology in the Hospital of Besançon (France) were screened for high risk HPV (HR HPV) infection. Risk factors were investigated through a questionnaire sent to all participants in 2010. HPV DNA was detected by HC2 and Probe Set assays. The overall prevalence for HR HPV and HPV16, 18 and/or HPV45 was 44.6% (95% CI, 42.5–46.7%) and 19% (95% CI, 17.3–20.7%), respectively. The response rate to the questionnaire was 22.6%. The prevalence of independent risk factors (age older than 19, smoking, and oral contraception) for HPV 16/18/45 infection in this population was less than 20%. Based on this study, HPV vaccination should be offered not only to teenage girls, but also to young women, regardless of their sexual activity.
Open Access: This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Download article (PDF)
View full text (HTML)

<Previous Article In Issue

Next Article In Issue>

Journal: Journal of Epidemiology and Global Health
Volume-Issue: 4 - 1
Pages: 35 - 43
Publication Date: 2014/01/23
ISSN (Online): 2210-6014
ISSN (Print): 2210-6006
DOI: 10.1016/j.jegh.2013.11.003 How to use a DOI?
Open Access: This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Cite this article

ris enw bib

TY  - JOUR
AU  - Ariane Baudu
AU  - Jean-Luc Prétet
AU  - Didier Riethmuller
AU  - Morgane Chotard
AU  - Christiane Mougin
AU  - Mariette Mercier
PY  - 2014
DA  - 2014/01/23
TI  - Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years
JO  - Journal of Epidemiology and Global Health
SP  - 35
EP  - 43
VL  - 4
IS  - 1
SN  - 2210-6014
UR  - https://doi.org/10.1016/j.jegh.2013.11.003
DO  - 10.1016/j.jegh.2013.11.003
ID  - Baudu2014
ER  -

download .riscopy to clipboard